Inventor · disambiguated record
David K. Williams
Also filed as: WILLIAMS DAVID K
31 granted patents·158 citations·filing 2000–2022
96Inventor score
Files withBRISTOL MYERS SQUIBB CO19FLEXUS BIOSCIENCES INC7INNATE TUMOR IMMUNITY INC3AMERICAN HOME PROD2
Top patents by PatentIndex Score
31 records- 0196US9643972B2Immunoregulatory agentsFLEXUS BIOSCIENCES INC·Filed 2015·Granted May 9, 2017·15 cites·47 claims
- 0296US9598422B2Immunoregulatory agentsFLEXUS BIOSCIENCES INC·Filed 2015·Granted Mar 21, 2017·21 cites·34 claims
- 0394US9790169B2IDO inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Oct 17, 2017·19 cites·27 claims
- 0493US10106546B2Immunoregulatory agentsFLEXUS BIOSCIENCES INC·Filed 2017·Granted Oct 23, 2018·6 cites·66 claims
- 0589US10533014B2Immunoregulatory agentsFLEXUS BIOSCIENCES INC·Filed 2018·Granted Jan 14, 2020·3 cites·20 claims
- 0689US6268360B11H-pyrido[2,3-b][1,5]benzodiazipine vasopressin agonistsAMERICAN HOME PROD·Filed 2000·Granted Jul 31, 2001·30 cites·7 claims
- 0787US11344543B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2018·Granted May 31, 2022·2 cites·25 claims
- 0887US7547782B2Met kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Jun 16, 2009·6 cites·17 claims
- 0986US10633342B2Inhibitors of indoleamine 2,3-dioxygenase and methods of their useBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Apr 28, 2020·2 cites·17 claims
- 1085US11066383B2Inhibitors of indoleamine 2,3-dioxygenase and methods of their useBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jul 20, 2021·3 cites·15 claims
- 1185US6297234B1Arylthiophene vasopressin agonistsAMERICAN HOME PROD·Filed 2000·Granted Oct 2, 2001·20 cites·11 claims
- 1283US10696648B2Inhibitors of indoleamine 2,3-dioxygenase and methods of their useBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jun 30, 2020·3 cites·20 claims
- 1383US10399933B2Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancerBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Sep 3, 2019·3 cites·13 claims
- 1482US10399932B2Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancerBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Sep 3, 2019·3 cites·13 claims
- 1578US9765018B2IDO inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Sep 19, 2017·4 cites·11 claims
- 1678US9758492B2IDO inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Sep 12, 2017·4 cites·11 claims
- 1777US11649212B2Inhibitors of indoleamine 2,3-dioxygenase and methods of their useBRISTOL MYERS SQUIBB CO·Filed 2018·Granted May 16, 2023·1 cites·4 claims
- 1877US10689331B2IDO inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jun 23, 2020·2 cites·17 claims
- 1976US12145927B2Inhibitors of indoleamine 2,3-dioxygenase and methods of their useBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Nov 19, 2024·1 cites·11 claims
- 2075US10544099B2Inhibitors of indoleamine 2,3-dioxygenase and methods of their useBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jan 28, 2020·1 cites·18 claims
- 2175US10167254B2IDO inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jan 1, 2019·1 cites·43 claims
- 2274US11447449B2Inhibitors of indoleamine 2,3-dioxygenase and methods of their useBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Sep 20, 2022·1 cites·9 claims
- 2374US6809102B2Cyano-substituted dihydropyrimidine compounds and their use to treat diseasesBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Oct 26, 2004·7 cites·32 claims
- 2473US12171756B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2022·Granted Dec 24, 2024·0 cites·10 claims
- 2566US11932601B2Immunoregulatory agentsFLEXUS BIOSCIENCES INC·Filed 2021·Granted Mar 19, 2024·0 cites·17 claims
- 2657US11242319B2Immunoregulatory agentsFLEXUS BIOSCIENCES INC·Filed 2015·Granted Feb 8, 2022·0 cites·23 claims
- 2756US10206893B2Immunoregulatory agentsFLEXUS BIOSCIENCES INC·Filed 2017·Granted Feb 19, 2019·0 cites·23 claims
- 2854US12391675B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2020·Granted Aug 19, 2025·0 cites·13 claims
- 2950US11066392B2Inhibitors of indoleamine 2,3-dioxygenase and methods of their useBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Jul 20, 2021·0 cites·24 claims
- 3049US12059420B2Inhibitors of indoleamine 2,3-dioxygenase and methods of their useBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Aug 13, 2024·0 cites·6 claims
- 3146US9783573B2IAP antagonistsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Oct 10, 2017·0 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when David K. Williams files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →